Utility, Benefits, and Risks of Newborn Genetic Screening Carrier Reports for Families

Overview

Journal J Glob Health

Specialties Health Services
Public Health

Date 2024 Feb 23

PMID 38389402

Authors

Xin Wang

Yun Sun

Jing-Yu Zhao

Xian-Wei Guan

Yan-Yun Wang

Dong-Yang Hong

Zhi-Lei Zhang

Ya-Hong Li

Pei-Ying Yang

Tao Jiang

Zheng-Feng Xu

Affiliations

Soon will be listed here.

Abstract

Background: Newborn genetic screening (NBGS) based on next-generation sequencing offers enhanced disease detection and better detection rates than traditional newborn screening. However, challenges remain, especially around reporting the NBGS carrier results. Therefore, we aimed to investigate the NBGS carrier parents' views on NBGS and NBGS reports in China.

Methods: We distributed a survey querying demographic information, knowledge and perceptions of NBGS, the impact of NBGS on a total of 2930 parents, and their decision-making to parents of newborns reported as carriers in NBGS in Nanjing, China in 2022.

Results: The average age of the survey respondents was 30.7 years (standard deviation = 3.6). Most (68.38%) felt informed about NBGS, especially women, the highly educated, and high earners. Nearly all (98.74%) saw NBGS as crucial for early disease detection, with 73.18% believing it positively impacts their future. However, 19.16% felt it might cause anxiety, especially among the less educated. Concerns included potential discrimination due to exposed genetic data and strained family ties. Many suggested NBGS coverage by medical insurance to ease financial burdens.

Conclusions: Through our study, we gained insights into parents' perspectives and concerns regarding the NBGS carrier result reporting, thus providing relevant information for further refinement and clinical promotion of the NBGS project.

References

Friedman Ross L, Clayton E . Ethical Issues in Newborn Sequencing Research: The Case Study of BabySeq. Pediatrics. 2019; 144(6). PMC: 6889970. DOI: 10.1542/peds.2019-1031. View

Tluczek A, Ersig A, Lee S . Psychosocial Issues Related to Newborn Screening: A Systematic Review and Synthesis. Int J Neonatal Screen. 2022; 8(4). PMC: 9589938. DOI: 10.3390/ijns8040053. View

Spiekerkoetter U, Bick D, Scott R, Hopkins H, Krones T, Gross E . Genomic newborn screening: Are we entering a new era of screening?. J Inherit Metab Dis. 2023; 46(5):778-795. DOI: 10.1002/jimd.12650. View

Sparks T . Expanded carrier screening: counseling and considerations. Hum Genet. 2019; 139(9):1131-1139. PMC: 7195224. DOI: 10.1007/s00439-019-02080-y. View

La Pean A, Farrell M . Initially misleading communication of carrier results after newborn genetic screening. Pediatrics. 2005; 116(6):1499-505. DOI: 10.1542/peds.2005-0449. View

Sahai I, Marsden D . Newborn screening. Crit Rev Clin Lab Sci. 2009; 46(2):55-82. DOI: 10.1080/10408360802485305. View

. Serving the family from birth to the medical home. Newborn screening: a blueprint for the future - a call for a national agenda on state newborn screening programs. Pediatrics. 2000; 106(2 Pt 2):389-422. View

Zheng Z, Liebers M, Zhelyazkova B, Cao Y, Panditi D, Lynch K . Anchored multiplex PCR for targeted next-generation sequencing. Nat Med. 2014; 20(12):1479-84. DOI: 10.1038/nm.3729. View

Milko L, Rini C, Lewis M, Butterfield R, Lin F, Paquin R . Evaluating parents' decisions about next-generation sequencing for their child in the NC NEXUS (North Carolina Newborn Exome Sequencing for Universal Screening) study: a randomized controlled trial protocol. Trials. 2018; 19(1):344. PMC: 6022715. DOI: 10.1186/s13063-018-2686-4. View

10.

Genetti C, Schwartz T, Robinson J, VanNoy G, Petersen D, Pereira S . Parental interest in genomic sequencing of newborns: enrollment experience from the BabySeq Project. Genet Med. 2018; 21(3):622-630. PMC: 6420384. DOI: 10.1038/s41436-018-0105-6. View

11.

Wang X, Guan X, Wang Y, Zhang Z, Li Y, Yang P . Current attitudes and preconceptions on newborn genetic screening in the Chinese reproductive-aged population. Orphanet J Rare Dis. 2022; 17(1):322. PMC: 9412816. DOI: 10.1186/s13023-022-02474-8. View

12.

Ceyhan-Birsoy O, Murry J, Machini K, Lebo M, Yu T, Fayer S . Interpretation of Genomic Sequencing Results in Healthy and Ill Newborns: Results from the BabySeq Project. Am J Hum Genet. 2019; 104(1):76-93. PMC: 6323417. DOI: 10.1016/j.ajhg.2018.11.016. View

13.

Botkin J, Belmont J, Berg J, Berkman B, Bombard Y, Holm I . Points to Consider: Ethical, Legal, and Psychosocial Implications of Genetic Testing in Children and Adolescents. Am J Hum Genet. 2015; 97(1):6-21. PMC: 4570999. DOI: 10.1016/j.ajhg.2015.05.022. View

14.

VanNoy G, Genetti C, McGuire A, Green R, Beggs A, Holm I . Challenging the Current Recommendations for Carrier Testing in Children. Pediatrics. 2019; 143(Suppl 1):S27-S32. PMC: 6433123. DOI: 10.1542/peds.2018-1099F. View

15.

Tan J, Zhang J, Sun R, Jiang Z, Wang Y, Ma D . Evaluating the performance of four assays for carrier screening of spinal muscular atrophy. Clin Chim Acta. 2023; 548:117496. DOI: 10.1016/j.cca.2023.117496. View

16.

Holm I, Agrawal P, Ceyhan-Birsoy O, Christensen K, Fayer S, Frankel L . The BabySeq project: implementing genomic sequencing in newborns. BMC Pediatr. 2018; 18(1):225. PMC: 6038274. DOI: 10.1186/s12887-018-1200-1. View

17.

Leppert K, Bisordi K, Nieto J, Maloney K, Guan Y, Dixon S . Genetic Counselors' Experience with and Opinions on the Management of Newborn Screening Incidental Carrier Findings. J Genet Couns. 2018; 27(6):1328-1340. PMC: 6209045. DOI: 10.1007/s10897-018-0258-0. View

18.

Oliver S, Dezateux C, Kavanagh J, Lempert T, Stewart R . Disclosing to parents newborn carrier status identified by routine blood spot screening. Cochrane Database Syst Rev. 2004; (4):CD003859. PMC: 11491188. DOI: 10.1002/14651858.CD003859.pub2. View

19.

Pereira S, Robinson J, Gutierrez A, Petersen D, Hsu R, Lee C . Perceived Benefits, Risks, and Utility of Newborn Genomic Sequencing in the BabySeq Project. Pediatrics. 2019; 143(Suppl 1):S6-S13. PMC: 6480393. DOI: 10.1542/peds.2018-1099C. View

20.

Farrell P, Langfelder-Schwind E, Farrell M . Challenging the dogma of the healthy heterozygote: Implications for newborn screening policies and practices. Mol Genet Metab. 2021; 134(1-2):8-19. DOI: 10.1016/j.ymgme.2021.08.008. View